• How to evaluate trade-offs between coverage, read length, throughput, cost, and sensitivity, dependent on goals
• When is it worth investing in deeper, more precise approaches versus high-throughput, population-level methods?
• How to combine multiple platforms
Moderator:
SIMONA CRISTEA, Head of Genomics & AI, Dana-Farber Cancer Institute
Panellists:
ZORA MODRUSAN, Senior Director of Genomics, Genentech
IOANNIS RAGOUSSIS, Professor, McGill Genome Centre




